COVID-19 clinical trial combines remdesivir with anti-inflammatory drug for one-two punch at SLU.

Kathleen Berger and Dr. Sarah George, MD, discuss a clinical trial that combines remdesivir, an experimental antiviral medication developed to treat Ebola, with baricitinib, an anti-inflammatory drug, as a treatment for COVID-19.

Bibliographic Details

Other Authors:	George, Sarah, active 2020 (practitioner.), Berger, Kathleen (Narrator)
Format:	Video
Language:	English
Language Notes:	Closed-captioned in English.
Published:	[Place of publication not identified] : Educate Today, 2020.
Subjects:	COVID-19 (Disease) > Treatment. Antiviral agents. Anti-inflammatory agents. Antiviral Agents Anti-Inflammatory Agents COVID-19 > Traitement. Antiviraux. Antiinflammatoires.
Online Access:	Connect to this streaming video